The Gratitude Gallery - A Positive Psychology Intervention

NCT04723251•University of Michigan

Summary

This study will assess the feasibility and acceptability of a positive psychology intervention, The Gratitude Gallery, for increasing gratitude in adults. The study hypothesizes that participants will find the activity feasible and acceptable and complete the intervention as directed. The project also hypothesizes that those that complete the intervention will show an increase in self-reported gratitude, as well as a decrease in symptoms of anxiety and depression.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Able to read/understand English and give consent
•Owns a smart phone capable of taking pictures
•Willing and able to comply with all aspects of study procedures
•PHQ-9 score greater or equal to 5 but less or equal to 14 with no suicidal ideation
•Generalized anxiety disorder (GAD-7) score greater or equal to 0 but less or equal to 9
•No plan to initiate a new program that could increase positive affect during the study period (e.g., psychotherapy, new exercise regimen, meditation classes)
•If on medication then stable (at least 3 months) on dose or not on medication

Exclusion Criteria

•Having a psychotic disorder active suicidality or severe depressive or anxiety symptoms
•Other factors that at the discretion of the investigators that would adversely affect study participation

Locations (1)

University of Michigan

Ann Arbor, Michigan, United States

Key Dates

Start Date

March 16, 2021

Primary Completion Date

November 2, 2021

Completion Date

November 2, 2021

Last Updated

December 17, 2021

Enrollment

ACTUAL participants

Conditions

DepressionAnxiety

Interventions

taking photographs

BEHAVIORAL

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 17, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Gratitude Gallery - A Positive Psychology Intervention

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures